News
21h
Zacks Investment Research on MSNGSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...
The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
The experts recommend 24-hour or “second-generation” antihistamines like cetirizine (Zyrtec) or fexofenadine (Allegra), which ...
New research from the Royal Veterinary College (RVC) has identified porcupine inhibition—a strategy that blocks a key ...
“The FDA heard from patient representatives that argued that the care partner requirement ruled out home treatment for a lot of patients,” he said. In 2017, a patient survey revealed 15% of ...
The RSV immunization campaign ended on April 1, 2025. Respiratory syncytial virus (RSV) immunization for babies consists of the administration of a preventive treatment to eligible children. The ...
The Allan Labor Government is keeping Victorian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting immunisation available free from tomorrow for eligible families until ...
An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for babies found it to be almost 90% effective in reducing hospitalization ...
Health bosses at the UK Health Security Agency (UKHSA) have warned to "stay at home" for 48 hours after norovirus symptoms stop, as you can still be infected with the highly contagious virus.
Home remedies, like nasal irrigation or certain essential oils, may help relieve some symptoms of allergies. But it’s best to identify the source of your allergy and follow your doctor’s advice.
Federal trial judges blocking presidential acts via nationwide injunctions are creating a serious conflict between the executive and judicial branches. The flood of such injunctions provoked ...
It does not necessarily reflect the view of The Herald. The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, according to early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results